Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

GlaxoSmithKline develops a second-generation HCV NS5A replication complex inhibitor

March 23, 2016

ContraVir initiates phase I/IIa trial of CMX-157 in chronic HBV infection

March 22, 2016

FDA first to approve Anthim for inhalation anthrax

March 22, 2016

Biota Pharmaceuticals sells antibiotic assets to Spero Therapeutics

March 18, 2016

EMA approves centralized review of Pulmaquin

March 18, 2016

MP-376 receives QIDP designation

March 17, 2016

Safety, tolerability and pharmacokinetics of LCB01-0371 in healthy volunteers

March 16, 2016

Taisho Pharmaceutical presents antibacterial agents

March 15, 2016

ViveBio and Butantan Institute collaborate to evaluate ViveST technology in dengue trial

March 15, 2016

MSD KK files application for approval of oral agents for chronic hepatitis C in Japan

March 14, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...